U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.1099G>A (p.Val367Met) AND not provided

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
Feb 21, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000440624.7

Allele description [Variation Report for NM_000162.5(GCK):c.1099G>A (p.Val367Met)]

NM_000162.5(GCK):c.1099G>A (p.Val367Met)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.1099G>A (p.Val367Met)
Other names:
NM_000162.5(GCK):c.1099G>A; p.Val367Met
HGVS:
  • NC_000007.14:g.44145651C>T
  • NG_008847.2:g.57520G>A
  • NM_000162.5:c.1099G>AMANE SELECT
  • NM_001354800.1:c.1099G>A
  • NM_001354801.1:c.88G>A
  • NM_001354802.1:c.-42G>A
  • NM_001354803.2:c.133G>A
  • NM_033507.3:c.1102G>A
  • NM_033508.3:c.1096G>A
  • NP_000153.1:p.Val367Met
  • NP_001341729.1:p.Val367Met
  • NP_001341730.1:p.Val30Met
  • NP_001341732.1:p.Val45Met
  • NP_277042.1:p.Val368Met
  • NP_277043.1:p.Val366Met
  • LRG_1074t1:c.1099G>A
  • LRG_1074t2:c.1102G>A
  • LRG_1074:g.57520G>A
  • LRG_1074p1:p.Val367Met
  • LRG_1074p2:p.Val368Met
  • NC_000007.13:g.44185250C>T
  • NC_000007.13:g.44185250C>T
  • NM_000162.3:c.1099G>A
Protein change:
V30M
Links:
dbSNP: rs1057521092
NCBI 1000 Genomes Browser:
rs1057521092
Molecular consequence:
  • NM_001354802.1:c.-42G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000162.5:c.1099G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.1099G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354801.1:c.88G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354803.2:c.133G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.1102G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.1096G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000521045GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Likely pathogenic
(Feb 21, 2024)
germlineclinical testing

Citation Link,

SCV002771529Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Likely pathogenic
(Aug 16, 2021)
unknownclinical testing

PubMed (10)
[See all records that cite these PMIDs]

SCV004295143Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Apr 28, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels.

Markwardt ML, Nkobena A, Ding SY, Rizzo MA.

Mol Endocrinol. 2012 Sep;26(9):1617-29. doi: 10.1210/me.2012-1183. Epub 2012 Jul 6.

PubMed [citation]
PMID:
22771492
PMCID:
PMC3434526

MODY2 in Asia: analysis of GCK mutations and clinical characteristics.

Zhou Y, Wang S, Wu J, Dong J, Liao L.

Endocr Connect. 2020 May;9(5):471-478. doi: 10.1530/EC-20-0074.

PubMed [citation]
PMID:
32375122
PMCID:
PMC7274558
See all PubMed Citations (11)

Details of each submission

From GeneDx, SCV000521045.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Published functional studies demonstrate this impacts posttranslational regulation of GCK (PMID: 19934346, 22771492); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; This variant is associated with the following publications: (PMID: 22771492, 21454584, 10426385, 10525657, 19934346, 19790256, 14517946, 15161764, 26698632, 34789923, 37725835, 9049484, 27256595, 36257325, 32375122, 31968686)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Athena Diagnostics, SCV002771529.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (10)

Description

This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. Assessment of experimental evidence suggests this variant results in abnormal protein function. Variant affected interaction with other proteins leading to reduced response to glucose (PMID: 21454584).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004295143.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects GCK function (PMID: 10426385, 10525657, 19934346, 21454584, 26698632). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GCK protein function. ClinVar contains an entry for this variant (Variation ID: 381598). This missense change has been observed in individual(s) with maturity onset diabetes of the young (PMID: 9049484, 27256595; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 367 of the GCK protein (p.Val367Met).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024